empagliflozin API

empagliflozin API

empagliflozin API

Min.Order / FOB Price:Get Latest Price

1 Gram

Negotiable

  • Min.Order :1 Gram
  • Purity: 99
  • Payment Terms : L/C,D/P,T/T

Keywords

empagliflozin; X5927; (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-((S)-tetrahydrofuran-3-yloxy)benzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol; Empagliflozin; CS-0940 empagliflozin(API)

Quick Details

  • Appearance:white power
  • Application:EMPAGLIFLOZIN
  • PackAge:DRUMS/CARTON
  • ProductionCapacity:10|Kilogram|Week
  • Storage:in sealed air resistant place
  • Transportation:air or sea or express delivery

Superiority:

Anqing World Chemical Co.,Ltd.Mainly responsible for the development of domestic and international business.In 2015,Haikang established the second branch,called Anqing Xuanyu Medical&Technology Co., Ltd, it is an R&D company that selects reliable technology and cooperative research partner for our corporation.

Haikang is committed to R&D,manufacture and sales of chemical raw materials API and intermediates.Meanwhile,we also provide services like product customization,process improvement,achievement transfer, etc. Through years effort,Haikang has made remarkable achievements in the R&D and production of anti-virus,antidiabetic,antineoplastic,beauty and whitening resist oxidation series API and intermediates.The main products are Ganciclovir, Sitagliptin, Vildagliptin, Silodosin and Imatinib API and Intermediates.

To deal with increasingly competition,Haikang adheres to “Customer is First,Technology is Leading,Quality is Life,Honesty for Developing”,and optimizes actively the products and better service to customers.

Details:

Empagliflozin is used for the treatment of adult patients with 2 diabetes who have not achieved sufficient blood sugar control in combination with diet and exercise to improve blood sugar control. It should not be used to treat type 1 Chemicalbook diabetes patients, patients with elevated blood or urine ketones (diabetic ketoacidosis), patients with severe kidney damage, end-stage kidney disease, and dialysis patients.

Empagliflozin is used for the treatment of adult patients with 2 diabetes who have not achieved sufficient blood sugar control in combination with diet and exercise to improve blood sugar control. It should not be used to treat type 1 Chemicalbook diabetes patients, patients with elevated blood or urine ketones (diabetic ketoacidosis), patients with severe kidney damage, end-stage kidney disease, and dialysis patients.

Empagliflozin (Empagliflozin), a type 2 sodium-dependent glucose cotransporter (SGLT-2, sodium-dependentglucosecotransporterChemicalbook2) inhibitor jointly developed by Boehringer Ingelheim and Eli Lilly and Company. SGLT-2 inhibitor is a new type of hypoglycemic agent, mainly by inhibiting the expression of SGLT-2, reducing the kidney's reabsorption of glucose, increasing the excretion of glucose in urine, thereby reducing the plasma glucose level, and its hypoglycemic effect does not depend on For β cell function and insulin resistance.

View All
Visit Store

You Might Also Like

Related Searches

Contact Supplier

Confirm to collect the product to my collection?

OKCancel

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View